In the spotlight: Nestle's Pfizer buy offers long-term baby food boost
Nestle has won through in the battle to acquire Pfizer's baby food business, securing an US$11.85bn deal that will see the world's largest infant nutrition group extend its lead in this fast-growing category. However, with a hefty price tag attached, the deal has not been warmly welcomed by investors. Katy Askew reports.
Get full access to all content, just $1 for 30 days
A Message From The Editor
just-food gives you the widest food market coverage.
Paid just-food members have unlimited access to all our exclusive content - including 15 years of archives.
I am so confident you will love complete access to our content that today I can offer you 30 days access for $1.
It’s our best ever membership offer – just for you.
Dean Best, editor of just-food
- Nomad's post-Iglo opportunities
- Focus: Can Arla jump-start UK flavoured milk?
- PepsiCo underlines the challenge on health
- Hershey's long-term confidence on China
- Comment: Nestle reacts to world of 3G and Buffett
- Tesco delists Rachel's Organic yoghurt range
- Hostess sale rumours hit headlines again
- Hershey cuts sales forecast on forex and China
- Bongrain investors approve name change
- BRF in JV with UK foodservice firm Invicta